Arvin Gouw is the founding CEO of Bacchus Therapeutics, developing small molecule inhibitors of cancer metabolic pathways. His work has been supported by the entrepreneurship program of SPARK at Stanford, MBC BioLabs and AbbVie Inc. Prior to Stanford and Harvard, Arvin did his fellowship on science and religion at Princeton. Arvin received his doctorate from Johns Hopkins University School of Medicine, master's degrees in philosophy from University of Pennsylvania, in theology from SMSU Ecumenical Institute of Theology, and in neuroscience from UC Berkeley.
https://orcid.org/0000-0002-9552-635X
Invited by: Naresh Sunkara
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
October 18, 2023 | 59 | -1 | -1.7% |
July 10, 2022 | 60 | +1 | +1.7% |
June 03, 2022 | 59 | +11 | +23.0% |
March 19, 2022 | 48 | +1 | +2.2% |
August 08, 2021 | 47 | +5 | +12.0% |